{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T17:58:12Z","timestamp":1788285492546,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T00:00:00Z","timestamp":1689897600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T00:00:00Z","timestamp":1689897600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Osteoporos"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>\n                           <jats:italic>Summary<\/jats:italic>\n                        <\/jats:title>\n                <jats:p>In an analysis of claims data from a city in Japan, male patients and patients with dementia were less likely to receive osteoporosis pharmacotherapy after hip fracture. Treatment initiation rate has improved between 2014 and 2017.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Older adults with recent hip fractures are at a high risk of recurrent fractures. However, the post-fracture care gap has been reported globally. This study examines factors associated with pharmacotherapy non-initiation within 1 year after hip surgery.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Using medical and long-term care (LTC) claims, and LTC needs certification data in Tsukuba City, Japan, we identified individuals aged 65 years or older who had hip fractures with subsequent surgical procedures between October 1, 2014, and December 31, 2017. Patient (age, sex, dementia, and comorbidities) and health service\u2013related characteristics (fiscal year, type of hospital, number of hospital beds, and admission to recovery phase rehabilitation wards) were examined. The association of these factors with non-pharmacotherapy for osteoporosis within 1 year after hip fracture using multivariable logistic models was analyzed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We identified 275 patients with hip fractures who did not receive pharmacotherapy pre-fracture. Forty percent of them received pharmacotherapy within 1 year of post-fracture. Male sex (odds ratio (OR) = 4.49 [2.14\u20139.44]) and dementia (OR = 1.90 [1.03\u20133.52]) were associated with no pharmacotherapy, whereas later fiscal year (OR = 0.64 [0.48\u20130.87]) and admission to rehabilitation wards (OR = 0.25 [0.14\u20130.46]) were associated with pharmacotherapy initiation within 1 year of post-fracture. Comorbidities were not associated with the initiation of pharmacotherapy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Pharmacotherapy for osteoporosis was less likely to be initiated after a hip fracture in male patients and patients with dementia. These patients should be considered for pharmacotherapy because they are at high risk of recurrent fractures.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s11657-023-01314-x","type":"journal-article","created":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T11:02:05Z","timestamp":1689937325000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Factors associated with non-initiation of osteoporosis pharmacotherapy after hip fracture: analysis of claims data in Japan"],"prefix":"10.1007","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6212-9270","authenticated-orcid":false,"given":"Tomoko","family":"Fujii","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Komiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoaki","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanako","family":"Tamiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,21]]},"reference":[{"key":"1314_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00198-003-1515-z","volume":"15","author":"S Boonen","year":"2004","unstructured":"Boonen S, Autier P, Barette M, Vanderschueren D, Lips P, Haentjens P (2004) Functional outcome and quality of life following hip fracture in elderly women: a prospective controlled study. Osteoporos Int 15:87\u201394. https:\/\/doi.org\/10.1007\/s00198-003-1515-z","journal-title":"Osteoporos Int"},{"key":"1314_CR2","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s001980170017","volume":"12","author":"JD Adachi","year":"2001","unstructured":"Adachi JD, Loannidis G, Berger C et al (2001) The influence of osteoporotic fractures on health-related quality of life in community-dwelling men and women across Canada. Osteoporos Int 12:903\u2013908. https:\/\/doi.org\/10.1007\/s001980170017","journal-title":"Osteoporos Int"},{"key":"1314_CR3","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1001\/jama.2009.1462","volume":"302","author":"CA Brauer","year":"2009","unstructured":"Brauer CA, Coca-Perraillon M, Cutler DM, Rosen AB (2009) Incidence and mortality of hip fractures in the United States. JAMA 302:1573\u20131579. https:\/\/doi.org\/10.1001\/jama.2009.1462","journal-title":"JAMA"},{"key":"1314_CR4","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1111\/joim.12586","volume":"281","author":"M Katsoulis","year":"2017","unstructured":"Katsoulis M, Benetou V, Karapetyan T et al (2017) Excess mortality after hip fracture in elderly persons from Europe and the USA: the CHANCES project. J Intern Med 281:300\u2013310. https:\/\/doi.org\/10.1111\/joim.12586","journal-title":"J Intern Med"},{"key":"1314_CR5","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s11657-022-01096-8","volume":"17","author":"T Mori","year":"2022","unstructured":"Mori T, Komiyama J, Fujii T et al (2022) Medical expenditures for fragility hip fracture in Japan: a study using the nationwide health insurance claims database. Arch Osteoporos 17:61. https:\/\/doi.org\/10.1007\/s11657-022-01096-8","journal-title":"Arch Osteoporos"},{"key":"1314_CR6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s00223-011-9545-6","volume":"90","author":"H Hagino","year":"2012","unstructured":"Hagino H, Sawaguchi T, Endo N, Ito Y, Nakano T, Watanabe Y (2012) The risk of a second hip fracture in patients after their first hip fracture. Calcif Tissue Int 90:14\u201321. https:\/\/doi.org\/10.1007\/s00223-011-9545-6","journal-title":"Calcif Tissue Int"},{"key":"1314_CR7","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1001\/jama.297.4.387","volume":"297","author":"JR Center","year":"2007","unstructured":"Center JR, Bliuc D, Nguyen TV, Eisman JA (2007) Risk of subsequent fracture after low-trauma fracture in men and women. JAMA 297:387\u2013394. https:\/\/doi.org\/10.1001\/jama.297.4.387","journal-title":"JAMA"},{"key":"1314_CR8","doi-asserted-by":"publisher","first-page":"499","DOI":"10.12669\/pjms.322.9435","volume":"32","author":"J Peng","year":"2016","unstructured":"Peng J, Liu Y, Chen L, Peng K, Xu Z, Zhang D, Xiang Z (2016) Bisphosphonates can prevent recurrent hip fracture and reduce the mortality in osteoporotic patient with hip fracture: a meta-analysis. Pak J Med Sci 32:499\u2013504. https:\/\/doi.org\/10.12669\/pjms.322.9435","journal-title":"Pak J Med Sci"},{"key":"1314_CR9","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1002\/jbmr.2202","volume":"29","author":"DH Solomon","year":"2014","unstructured":"Solomon DH, Johnston SS, Boytsov NN, McMorrow D, Lane JM, Krohn KD (2014) Osteoporosis medication use after hip fracture in U.S. patients between 2002 and 2011. J Bone Miner Res 29:1929\u20131937. https:\/\/doi.org\/10.1002\/jbmr.2202","journal-title":"J Bone Miner Res"},{"key":"1314_CR10","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.amjmed.2015.01.014","volume":"128","author":"SC Kim","year":"2015","unstructured":"Kim SC, Kim MS, Sanf\u00e9lix-Gimeno G et al (2015) Use of osteoporosis medications after hospitalization for hip fracture: a cross-national study. Am J Med 128:519\u201326.e1. https:\/\/doi.org\/10.1016\/j.amjmed.2015.01.014","journal-title":"Am J Med"},{"key":"1314_CR11","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1007\/s00198-014-2827-x","volume":"25","author":"A Wilk","year":"2014","unstructured":"Wilk A, Sajjan S, Modi A, Fan CP, Mavros P (2014) Post-fracture pharmacotherapy for women with osteoporotic fracture: analysis of a managed care population in the USA. Osteoporos Int 25:2777\u20132786. https:\/\/doi.org\/10.1007\/s00198-014-2827-x","journal-title":"Osteoporos Int"},{"key":"1314_CR12","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/s11657-021-00992-9","volume":"16","author":"S Nakatoh","year":"2021","unstructured":"Nakatoh S, Fujimori K, Ishii S, Tamaki J, Okimoto N, Ogawa S, Iki M (2021) Insufficient increase in bone mineral density testing rates and pharmacotherapy after hip and vertebral fracture: analysis of the National Database of Health Insurance Claims and Specific Health Checkups of Japan. Arch Osteoporos 16:130. https:\/\/doi.org\/10.1007\/s11657-021-00992-9","journal-title":"Arch Osteoporos"},{"key":"1314_CR13","doi-asserted-by":"publisher","first-page":"579","DOI":"10.12809\/hkmj187227","volume":"24","author":"MY Cheung","year":"2018","unstructured":"Cheung MY, Ho AW, Wong SH (2018) Postfracture care gap: a retrospective population-based analysis of Hong Kong from 2009 to 2012. Hong Kong Med J 24:579\u2013583. https:\/\/doi.org\/10.12809\/hkmj187227","journal-title":"Hong Kong Med J"},{"key":"1314_CR14","doi-asserted-by":"publisher","first-page":"e180826","DOI":"10.1001\/jamanetworkopen.2018.0826","volume":"1","author":"RJ Desai","year":"2018","unstructured":"Desai RJ, Mahesri M, Abdia Y, Barberio J, Tong A, Zhang D, Mavros P, Kim SC, Franklin JM (2018) Association of osteoporosis medication use after hip fracture with prevention of subsequent nonvertebral fractures: an instrumental variable analysis. JAMA Netw Open 1:e180826. https:\/\/doi.org\/10.1001\/jamanetworkopen.2018.0826","journal-title":"JAMA Netw Open"},{"key":"1314_CR15","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1007\/s11657-021-00988-5","volume":"16","author":"M Kanahori","year":"2021","unstructured":"Kanahori M, Matsumoto Y, Fujiwara T et al (2021) Predictive factors of non-treatment and non-persistence to osteoporosis medication after fragility hip fractures at 3 years after discharge: a multicentre, prospective cohort study in the northern Kyushu district of Japan. Arch Osteoporos 16:132. https:\/\/doi.org\/10.1007\/s11657-021-00988-5","journal-title":"Arch Osteoporos"},{"key":"1314_CR16","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00198-013-2430-6","volume":"25","author":"DE Beaton","year":"2014","unstructured":"Beaton DE, Dyer S, Jiang D, Sujic R, Slater M, Sale JE, Bogoch ER, Osteoporosis Fracture Clinic Screening Program Evaluation Team (2014) Factors influencing the pharmacological management of osteoporosis after fragility fracture: results from the Ontario Osteoporosis Strategy\u2019s fracture clinic screening program. Osteoporos Int 25:289\u2013296. https:\/\/doi.org\/10.1007\/s00198-013-2430-6","journal-title":"Osteoporos Int"},{"key":"1314_CR17","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1007\/s00774-017-0869-9","volume":"36","author":"A Oyamada","year":"2018","unstructured":"Oyamada A, Matsumoto Y, Wakata Y et al (2018) Characteristics of patients with fragility hip fractures in the northern Kyushu district in Japan: a multicenter prospective registry based on an electronic data capture system. J Bone Miner Metab 36:596\u2013604. https:\/\/doi.org\/10.1007\/s00774-017-0869-9","journal-title":"J Bone Miner Metab"},{"key":"1314_CR18","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1007\/s00198-003-1507-z","volume":"14","author":"AR McLellan","year":"2003","unstructured":"McLellan AR, Gallacher SJ, Fraser M, McQuillian C (2003) The fracture liaison service: success of a program for the evaluation and management of patients with osteoporotic fracture. Osteoporos Int 14:1028\u20131034. https:\/\/doi.org\/10.1007\/s00198-003-1507-z","journal-title":"Osteoporos Int"},{"key":"1314_CR19","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.2106\/JBJS.L.00223","volume":"96","author":"KM Huntjens","year":"2014","unstructured":"Huntjens KM, van Geel TA, van den Bergh JP, van Helden S, Willems P, Winkens B, Eisman JA, Geusens PP, Brink PR (2014) Fracture liaison service: impact on subsequent nonvertebral fracture incidence and mortality. J Bone Joint Surg Am 96:e29. https:\/\/doi.org\/10.2106\/JBJS.L.00223","journal-title":"J Bone Joint Surg Am"},{"key":"1314_CR20","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.bone.2018.03.018","volume":"111","author":"CH Wu","year":"2018","unstructured":"Wu CH, Tu ST, Chang YF, Chan DC, Chien JT, Lin CH, Singh S, Dasari M, Chen JF, Tsai KS (2018) Fracture liaison services improve outcomes of patients with osteoporosis-related fractures: a systematic literature review and meta-analysis. Bone 111:92\u2013100. https:\/\/doi.org\/10.1016\/j.bone.2018.03.018","journal-title":"Bone"},{"key":"1314_CR21","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.afos.2019.09.003","volume":"5","author":"H Hagino","year":"2019","unstructured":"Hagino H, Wada T (2019) Osteoporosis liaison service in Japan. Osteoporos Sarcopenia 5:65\u201368. https:\/\/doi.org\/10.1016\/j.afos.2019.09.003","journal-title":"Osteoporos Sarcopenia"},{"key":"1314_CR22","unstructured":"City of Tsukuba (2014). Statistics. https:\/\/www.city.tsukuba.lg.jp\/shisei\/joho\/toukei\/1002336.html. Accessed 31 Jul 2022"},{"key":"1314_CR23","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/ggi.14393","volume":"22","author":"N Kuroda","year":"2022","unstructured":"Kuroda N, Iwagami M, Hamada S, Komiyama J, Mori T, Tamiya N (2022) Associations of polypharmacy and drugs with sedative or anticholinergic properties with the risk of long-term care needs certification among older adults in Japan: A population-based, nested case-control study. Geriatr Gerontol Int 22:497\u2013504. https:\/\/doi.org\/10.1111\/ggi.14393","journal-title":"Geriatr Gerontol Int"},{"key":"1314_CR24","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.jos.2017.06.003","volume":"22","author":"H Hagino","year":"2017","unstructured":"Hagino H, Endo N, Harada A, Iwamoto J, Mashiba T, Mori S, Ohtori S, Sakai A, Takada J, Yamamoto T (2017) Survey of hip fractures in Japan: recent trends in prevalence and treatment. J Orthop Sci 22:909\u2013914. https:\/\/doi.org\/10.1016\/j.jos.2017.06.003","journal-title":"J Orthop Sci"},{"key":"1314_CR25","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","volume":"43","author":"H Quan","year":"2005","unstructured":"Quan H, Sundararajan V, Halfon P, Fong A, Burnand B, Luthi JC, Saunders LD, Beck CA, Feasby TE, Ghali WA (2005) Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 43:1130\u20131139. https:\/\/doi.org\/10.1097\/01.mlr.0000182534.19832.83","journal-title":"Med Care"},{"key":"1314_CR26","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11657-018-0448-2","volume":"13","author":"T Mori","year":"2018","unstructured":"Mori T, Tamiya N, Jin X, Jeon B, Yoshie S, Iijima K, Ishizaki T (2018) Estimated expenditures for hip fractures using merged healthcare insurance data for individuals aged \u2265\u200975 years and long-term care insurance claims data in Japan. Arch Osteoporos 13:37. https:\/\/doi.org\/10.1007\/s11657-018-0448-2","journal-title":"Arch Osteoporos"},{"key":"1314_CR27","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12877-019-1057-7","volume":"19","author":"T Mori","year":"2019","unstructured":"Mori T, Hamada S, Yoshie S, Jeon B, Jin X, Takahashi H, Iijima K, Ishizaki T, Tamiya N (2019) The associations of multimorbidity with the sum of annual medical and long-term care expenditures in Japan. BMC Geriatr 19:69. https:\/\/doi.org\/10.1186\/s12877-019-1057-7","journal-title":"BMC Geriatr"},{"key":"1314_CR28","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1111\/ggi.13243","volume":"18","author":"H Noda","year":"2018","unstructured":"Noda H, Yamagishi K, Ikeda A, Asada T, Iso H (2018) Identification of dementia using standard clinical assessments by primary care physicians in Japan. Geriatr Gerontol Int 18:738\u2013744. https:\/\/doi.org\/10.1111\/ggi.13243","journal-title":"Geriatr Gerontol Int"},{"key":"1314_CR29","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1002\/gps.5041","volume":"34","author":"N Kuroda","year":"2019","unstructured":"Kuroda N, Hamada S, Sakata N, Jeon B, Iijima K, Yoshie S, Ishizaki T, Jin X, Watanabe T, Tamiya N (2019) Antipsychotic use and related factors among people with dementia aged 75 years or older in Japan: a comprehensive population-based estimation using medical and long-term care data. Int J Geriatr Psychiatry 34:472\u2013479. https:\/\/doi.org\/10.1002\/gps.5041","journal-title":"Int J Geriatr Psychiatry"},{"key":"1314_CR30","volume-title":"Japanese 2015 guidelines for prevention and treatment of osteoporosis (in Japanese)","author":"Japan Osteoporosis Society","year":"2015","unstructured":"Japan Osteoporosis Society, the Japanese Society for Bone and Mineral Research, Japan Osteoporosis Foundation (2015) Japanese 2015 guidelines for prevention and treatment of osteoporosis (in Japanese). Life Science Publishing"},{"key":"1314_CR31","doi-asserted-by":"publisher","first-page":"2623","DOI":"10.1007\/s00198-018-4759-3","volume":"29","author":"CT Yeam","year":"2018","unstructured":"Yeam CT, Chia S, Tan HCC, Kwan YH, Fong W, Seng JJB (2018) A systematic review of factors affecting medication adherence among patients with osteoporosis. Osteoporos Int 29:2623\u20132637. https:\/\/doi.org\/10.1007\/s00198-018-4759-3","journal-title":"Osteoporos Int"},{"key":"1314_CR32","doi-asserted-by":"publisher","first-page":"11784","DOI":"10.1038\/s41598-017-10899-6","volume":"7","author":"A Garc\u00eda-Sempere","year":"2017","unstructured":"Garc\u00eda-Sempere A, Hurtado I, Sanf\u00e9lix-Genov\u00e9s J, Rodr\u00edguez-Bernal CL, Gil Orozco R, Peir\u00f3 S, Sanf\u00e9lix-Gimeno G (2017) Primary and secondary non-adherence to osteoporotic medications after hip fracture in Spain. The PREV2FO population-based retrospective cohort study. Sci Rep 7:11784. https:\/\/doi.org\/10.1038\/s41598-017-10899-6","journal-title":"Sci Rep"},{"key":"1314_CR33","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1097\/EDE.0b013e3181e89905","volume":"21","author":"S Deandrea","year":"2010","unstructured":"Deandrea S, Lucenteforte E, Bravi F, Foschi R, La Vecchia C, Negri E (2010) Risk factors for falls in community-dwelling older people: a systematic review and meta-analysis. Epidemiol (Camb Mass) 21:658\u2013668. https:\/\/doi.org\/10.1097\/EDE.0b013e3181e89905","journal-title":"Epidemiol (Camb Mass)"},{"key":"1314_CR34","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1002\/jbmr.2393","volume":"30","author":"D Bliuc","year":"2015","unstructured":"Bliuc D, Alarkawi D, Nguyen TV, Eisman JA, Center JR (2015) Risk of subsequent fractures and mortality in elderly women and men with fragility fractures with and without osteoporotic bone density: the Dubbo Osteoporosis Epidemiology Study. J Bone Miner Res 30:637\u2013646. https:\/\/doi.org\/10.1002\/jbmr.2393","journal-title":"J Bone Miner Res"},{"key":"1314_CR35","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1001\/jama.2009.50","volume":"301","author":"D Bliuc","year":"2009","unstructured":"Bliuc D, Nguyen ND, Milch VE, Nguyen TV, Eisman JA, Center JR (2009) Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA 301:513\u2013521. https:\/\/doi.org\/10.1001\/jama.2009.50","journal-title":"JAMA"},{"key":"1314_CR36","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00774-020-01093-2","volume":"38","author":"S Nakatoh","year":"2020","unstructured":"Nakatoh S, Fujimori K, Tamaki J, Okimoto N, Ogawa S, Iki M (2020) Insufficient increase in bone mineral density testing rates and pharmacotherapy after hip fracture in Japan. J Bone Miner Metab 38:589\u2013596. https:\/\/doi.org\/10.1007\/s00774-020-01093-2","journal-title":"J Bone Miner Metab"},{"key":"1314_CR37","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00198-015-3280-1","volume":"27","author":"JH Yong","year":"2016","unstructured":"Yong JH, Masucci L, Hoch JS, Sujic R, Beaton D (2016) Cost-effectiveness of a fracture liaison service--a real-world evaluation after 6 years of service provision. Osteoporos Int 27:231\u2013240. https:\/\/doi.org\/10.1007\/s00198-015-3280-1","journal-title":"Osteoporos Int"},{"key":"1314_CR38","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s11657-020-00720-9","volume":"15","author":"J Martin","year":"2020","unstructured":"Martin J, Viprey M, Castagne B, Barral M, Chapurlat R, Julien C, Serrier H, Schott AM (2020) Cost-effectiveness analyses of interventions to improve osteoporosis care in France. Arch Osteoporos 15:42. https:\/\/doi.org\/10.1007\/s11657-020-00720-9","journal-title":"Arch Osteoporos"},{"key":"1314_CR39","doi-asserted-by":"publisher","first-page":"107750","DOI":"10.1016\/j.diabres.2019.05.029","volume":"155","author":"T Sugiyama","year":"2019","unstructured":"Sugiyama T, Imai K, Ihana-Sugiyama N et al (2019) Variation in process quality measures of diabetes care by region and institution in Japan during 2015\u20132016: an observational study of nationwide claims data. Diabetes Res Clin Pract 155:107750. https:\/\/doi.org\/10.1016\/j.diabres.2019.05.029","journal-title":"Diabetes Res Clin Pract"},{"key":"1314_CR40","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s00198-020-05308-0","volume":"31","author":"J Martin","year":"2020","unstructured":"Martin J, Viprey M, Castagne B, Merle B, Giroudon C, Chapurlat R, Schott AM (2020) Interventions to improve osteoporosis care: a systematic review and meta-analysis. Osteoporos Int 31:429\u2013446. https:\/\/doi.org\/10.1007\/s00198-020-05308-0","journal-title":"Osteoporos Int"}],"container-title":["Archives of Osteoporosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-023-01314-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11657-023-01314-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-023-01314-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,4]],"date-time":"2024-01-04T13:35:24Z","timestamp":1704375324000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11657-023-01314-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,21]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1314"],"URL":"https:\/\/doi.org\/10.1007\/s11657-023-01314-x","relation":{},"ISSN":["1862-3514"],"issn-type":[{"value":"1862-3514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,21]]},"assertion":[{"value":"16 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in this study were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study formal consent is not required. This study was approved by the Medical Ethics Committee of the University of Tsukuba (approval number 1445-10).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"103"}}